Granula Therapeutics: Granular Therapeutics to accelerate de

Clinical candidate selection finalised for lead programme targeting mast-cell driven diseases Dermatology industry veteran Thibaud Portal, PhD appointed as CEO LONDON, March 30, 2023

Related Keywords

London , City Of , United Kingdom , Jamie Coleman , Orla Cunningham , Francesco De Rubertis , Jonny Finlay , Brian Kim , Pfizer Biomedicine Design Group , Pfizer , Thibaud Portal , Granular Therapeutics , Scientific Advisory Board , Chief Executive , Prescription Medicines , Chief Executive Officer , United Kingdom Based , Biotech Ultrahuman , Lockbody Therapeutics , Senior Director , Biomedicine Design Group , Granula , Herapeutics , Granular , Ccelerate , Development , Text , Generation , Pipeline , Reating , Mast , Fell , Riven , Diseases ,